Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
about
Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing.Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis.
P2860
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
@en
type
label
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
@en
prefLabel
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
@en
P2860
P356
P1433
P1476
Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
@en
P2093
Bochra Tourki
Ganesh Halade
P2860
P356
10.1096/FJ.201700109R
P407
P577
2017-06-22T00:00:00Z